Supaglutide
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2/3 · Completed · Enrollment 620
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| supaglutide RP3D dose+metformin | n/r | n/r | n/r | n/r |
| placebo+metformin | n/r | n/r | n/r | n/r |
Not shown
- supaglutide RP3D dose+metformin: endpoint not reported
- placebo+metformin: endpoint not reported